glp 1 liver enzymes Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty disease (NAFLD) and non-alcoholic steatohepatitis (NASH) Why are GLP-1 agonists being

Researchers found weight returns far faster after stopping GLP-1 drugs than after diet or exercise programmes On average, patients regained weight at a rate of nearly half a kilogram per month Health experts say the findings underscore obesity as a chronic condition, not a short-term problem Nothing lasts forever, including the pounds shed in a GLP-1 program

Neither group regained any bone density, she said

However, patients should be screened for contraindications, such as a history of pancreatitis or certain gastrointestinal conditions

[DOI] [PubMed] [Google Scholar] 47.Munir K.M., Lamos E.M

ACA Individual and Family Plans: BCBSIL vs

Available online: 136.Krajewski P.K., Zotowska A., Szepietowski J.C